“…9 To date, there are 6, 50, and 88 pathogenic mutations described throughout GATM, GAMT, and SLC6A8 genes, respectively. 18,19 A clinical diagnosis of CDS is based on the determination of an abnormal ratio of creatine-to-creatinine and guanidinoacetate-to-creatinine in spot urine; altered excretion of creatine, guanidinoacetate, and creatinine measured in 24-houre urine collections; altered concentration of these metabolites in blood, or depletion of creatine in brain assessed with in vivo magnetic resonance (MR) spectroscopy. 9,20,21 Each of the disorders has a pathognomonic biochemical phenotype that allows the differentiation between them.…”